Alps Advisors Inc Molecular Templates, Inc. Transaction History

Alps Advisors Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$3.37 - $6.87 $231,899 - $472,745	-68,813 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.78 - $7.86 $29,298 - $39,842	-5,069 Reduced 6.86%	68,813 $462,000
Q2 2021 Aug 11, 2021	SELL	$7.82 - $12.44 $129,116 - $205,396	-16,511 Reduced 18.27%	73,882 $578,000
Q1 2021 May 07, 2021	BUY	$9.33 - $14.05 $1,520 - $2,290	163 Added 0.18%	90,393 $1.14 Million
Q4 2020 Feb 03, 2021	BUY	$8.48 - $12.23 $225,339 - $324,987	26,573 Added 41.74%	90,230 $847,000
Q3 2020 Nov 04, 2020	BUY	$9.99 - $14.41 $13,056 - $18,833	1,307 Added 2.1%	63,657 $695,000
Q2 2020 Aug 05, 2020	BUY	$12.28 - $17.63 $399,873 - $574,085	32,563 Added 109.32%	62,350 $860,000
Q2 2018 Jul 25, 2018	SELL	$5.19 - $9.71 $32,515 - $60,833	-6,265 Reduced 17.38%	29,787 $298,000
Q1 2018 May 01, 2018	BUY	$8.0 - $12.96 $50,120 - $81,194	6,265 Added 21.03%	36,052 $288,000
Q4 2017 Feb 05, 2018	BUY	$7.04 - $11.31 $209,700 - $336,890	29,787	29,787 $298,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $7.33M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.